Confronto
Teduglutid vs. Triptorelin
Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.
Identità
Categoria
Ricerca (altro)
Ricerca (altro)
N. CAS
197922-42-2
57773-63-4
Peso molecolare
3752.13 g/mol
1311.45 g/mol
Emivita
nessun dato
3 h
Sequenza
nessun dato
pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2Meccanismo d'azione
Teduglutid
Teduglutide activates the GLP-2 receptor, promoting growth and regeneration of small-intestinal villi, increasing nutrient and fluid absorption and thereby reducing dependence on parenteral nutrition. The glycine substitution at position 2 makes it resistant to rapid breakdown by DPP-4.
Triptorelin
Triptorelin binds with high affinity to the GnRH receptor in the pituitary. After initial stimulation of LH and FSH secretion (flare phase, about 1-2 weeks), receptor desensitisation follows with consecutive gonadotropin suppression. This results in a reversible chemical castration: in men testosterone, in women oestrogen suppression to the postmenopausal range.
Base di evidenze
Evidenza più alta
RCT sull'uomo
RCT sull'uomo
Studi
2
4
di cui sull'uomo
2
4
Effetti registrati
2
3
Contraddizioni aperte
0
0
Eventi avversi documentati
2
3
Stato legale
Voci complete
Frequently asked questions
- What is the difference between Teduglutid and Triptorelin?
- Teduglutid is classified as "Ricerca (altro)", while Triptorelin is classified as "Ricerca (altro)". Teduglutid: Teduglutide is a DPP-4-resistant analog of GLP-2 (glucagon-like peptide-2). It promotes growth and function of the intestinal mucosa and is approved for treating short bowel syndrome. Triptorelin: Synthetic decapeptide GnRH agonist with increased affinity over native gonadotropin-releasing hormone. FDA- and EMA-approved since the 1980s for prostate cancer, endometriosis and precocious puberty. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Teduglutid or Triptorelin?
- The highest available evidence level is "RCT sull'uomo" for Teduglutid and "RCT sull'uomo" for Triptorelin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Teduglutid and Triptorelin in Germany and the United States?
- Germania: Teduglutid — Su prescrizione, Triptorelin — Su prescrizione. Stati Uniti: Teduglutid — Su prescrizione, Triptorelin — Su prescrizione. These are factual summaries with source and review date on the individual pages.